10-Q: Global Technologies Reports Q3 2026 Results, Focuses on Core Businesses

Sentiment:

Quarterly Report


Global Technologies, Ltd. filed its Q3 2026 Form 10-Q, detailing a strategic shift towards its healthcare and technology-enabled services subsidiaries, Primecare Supply and GTLL Advisory, while reporting a net loss.

Capital raiseThe company issued 30,000 shares of Series P Preferred Stock in February 2026 for cash proceeds of $30,000.The company issued 200,000 shares of Series P Preferred Stock in August 2025 for cash proceeds of $200,000.Management's plans to mitigate going concern issues include securing additional funding through corporate partnerships, licensing revenue agreements, issuing additional convertible debentures, and issuing public or private equity securities, including selling common stock through an at-the-market facility (ATM).
Worse than expectedThe company reported a net loss for the nine months ended March 31, 2026 ($170,524) compared to a net income in the prior year period ($24,055).Net revenue decreased to $325,507 for the nine months ended March 31, 2026, from $666,115 in the prior year period.Operating expenses increased for the nine months ended March 31, 2026 ($755,260) compared to the prior year period ($617,082).Cash and cash equivalents decreased to $38,178 as of March 31, 2026, from $68,108 as of June 30, 2025.The company's financial statements indicate substantial doubt about its ability to continue as a going concern.

Summary

  • Global Technologies, Ltd. reported its financial results for the nine months ended March 31, 2026, and the third quarter of fiscal year 2026.
  • The company's revenue for the nine months ended March 31, 2026, was $642,822, with $101,529 generated in the third quarter.
  • Net revenue for the nine months was $325,507, a decrease from $666,115 in the same period of the prior year.
  • The company reported a net loss of $170,524 for the nine months ended March 31, 2026, compared to a net income of $24,055 for the same period in fiscal year 2025.
  • For the three months ended March 31, 2026, the net loss was $191,963, compared to a net loss of $193,297 for the same period in fiscal year 2025.
  • Cash and cash equivalents stood at $38,178 as of March 31, 2026, a decrease from $68,108 as of June 30, 2025.
  • The company has a history of net losses and an accumulated deficit of $167,726,161 as of March 31, 2026, raising substantial doubt about its ability to continue as a going concern.
  • Management is focused on rebuilding its operating platform and developing its subsidiaries, Primecare Supply, LLC and GTLL Advisory Group, LLC.
  • The company has transitioned from a prior wholesale model (10 Fold Services) to a direct-to-clinic procurement and advisory platform.
  • There are no pending legal proceedings against the company.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing as negative due to the continued net losses, declining revenues, and significant going concern uncertainties, despite strategic business realignments.

Positives

  • The company is actively transitioning its business model to focus on its core subsidiaries, Primecare Supply, LLC and GTLL Advisory Group, LLC, which are in the healthcare, wellness, and technology-enabled services sectors.
  • Primecare Supply is leveraging its Sinq Ops technology to streamline pharmaceutical supply chains and connect manufacturers with medical clinics.
  • GTLL Advisory is positioned to provide strategic consulting and advisory services to small and mid-sized enterprises in the health and wellness industry.
  • The company has diversified its supplier relationships for Primecare Supply, moving away from a single supplier model.
  • Series P Preferred Stock issuances provided $230,000 in cash proceeds during the nine months ended March 31, 2026.

Negatives

  • The company reported a net loss of $170,524 for the nine months ended March 31, 2026, and a net loss of $191,963 for the three months ended March 31, 2026.
  • There is substantial doubt about the company's ability to continue as a going concern due to a history of net losses and a low cash balance ($38,178 as of March 31, 2026).
  • Total liabilities ($1,136,202) significantly exceed total assets ($42,399) as of March 31, 2026, resulting in a stockholders' deficiency of $1,093,803.
  • Net revenue decreased to $325,507 for the nine months ended March 31, 2026, from $666,115 in the prior year period.
  • Operating expenses increased to $755,260 for the nine months ended March 31, 2026, from $617,082 in the prior year period.
  • The company's disclosure controls and procedures were not effective as of March 31, 2026, due to resource constraints and a lack of personnel with sufficient GAAP knowledge.
  • The company has not established an audit committee and lacks independent outside directors.

Risks

  • The company's ability to effectively execute its business plan.
  • The ability to manage expansion, growth, and operating expenses.
  • The ability to protect brands and reputation.
  • The ability to repay debts.
  • Reliance on third-party suppliers outside of the United States.
  • The ability to evaluate and measure business, prospects, and performance metrics.
  • Competition in a highly competitive and evolving industry.
  • The ability to respond and adapt to changes in technology and customer behavior.
  • Risks associated with completed or potential acquisitions, dispositions, and strategic growth opportunities.
  • Risks related to the anticipated timing of closing potential acquisitions.
  • Risks related to the integration of potential or completed acquisitions.
  • The company's liquidity remains limited and dependent on continued revenue growth, disciplined expense management, and additional financing.
  • There is no assurance that sufficient funds will be generated from operations or available through external sources, which could force the company to curtail or cease operations.
  • Any required funds may not be available on attractive terms or could have a significant dilutive effect on existing shareholders.

Future Outlook

Management expects GTLL Advisory to commence revenue-generating operations in fiscal year 2026. The company expects that losses may continue during the development and growth stage of its subsidiaries until revenue growth and gross profit are sufficient to absorb corporate overhead and operating expenses. The company intends to continue managing its cash resources carefully while supporting the growth of Primecare Supply, LLC and GTLL Advisory Group, LLC.

Management Comments

  • Management believes Primecare Supply represents a core growth engine for Global Technologies, Ltd., offering scalable infrastructure, recurring transaction-based revenue, and a technology-enabled compliance advantage in the expanding health and wellness market.
  • Management expects GTLL Advisory to contribute to the Companys fiscal 2026 operating plan by providing strategic advisory services, business transformation support, and operational consulting services.
  • Management believes the transition to a direct-to-clinic procurement platform by Primecare Supply may result in lower reported gross revenue than the prior wholesale model, but may provide better long-term economics.
  • Management believes the decision to unwind the GOe3 acquisition allowed Global to reallocate resources toward its core business segments in health technology, procurement, and strategic advisory services.
  • Management continues to evaluate operating performance separately from non-cash and non-operating items, including financing-related accounting entries, derivative liability adjustments, and other fair value adjustments that may impact reported results.

Industry Context

StockSavvy.ai notes that Global Technologies, Ltd. is navigating a challenging market characterized by a shift towards specialized, technology-enabled services within the healthcare and wellness sectors. The company's strategic pivot to Primecare Supply and GTLL Advisory aligns with industry trends favoring B2B procurement platforms and data-driven consulting, but faces significant execution risk given its current financial position and operational history.

Comparison to Industry Standards

  • The company's net revenue of $325,507 for the nine months ended March 31, 2026, is significantly lower than many established players in the healthcare procurement and advisory services sectors.
  • The reported net loss and substantial accumulated deficit indicate a financial performance that is not in line with industry standards for companies seeking sustainable growth and profitability.
  • The company's reliance on private placements for capital, as evidenced by the Series P Preferred Stock issuances, is a common strategy for early-stage or turnaround companies but contrasts with the access to public markets or larger debt facilities available to more established industry participants.
  • The disclosure of ineffective internal controls and lack of an audit committee are significant deviations from corporate governance best practices observed in leading companies within the healthcare and technology sectors.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Disclosure Controls and ProceduresDisclosure controls and procedures were not effective as of March 31, 2026, due to resource constraints and a lack of personnel with sufficient GAAP knowledge.2026-03-31Potential for material misstatements or omissions in financial reporting.
Internal Control over Financial ReportingSignificant deficiencies and material weaknesses identified, including lack of sufficient personnel with GAAP knowledge, leading to potential failure to perform timely internal control and reviews.2026-03-31Compromises the reliability of financial reporting.
Audit CommitteeThe company has not established an audit committee.N/ALack of independent oversight of financial reporting and internal controls.
Independent DirectorsThe company lacks independent outside directors on its Board of Directors.N/AReduced independent oversight and governance.

Legal Proceedings

  • There is no pending litigation involving the Company at this time.

Related Party Transactions

  • Loans payable to related parties were $0 as of March 31, 2026, down from $100 as of June 30, 2025.

Stakeholder Impact

  • Shareholders: Continued net losses and going concern uncertainty pose significant risks to shareholder value. Potential future capital raises may be dilutive.
  • Employees: The company's financial instability could impact job security and future compensation.
  • Creditors: The company's weak financial position and going concern issues may affect its ability to meet debt obligations.
  • Suppliers: The company's financial health could impact its ability to pay suppliers on time.

Next Steps

  • Management expects GTLL Advisory to commence revenue-generating operations in fiscal year 2026.
  • The company intends to continue managing its cash resources carefully while supporting the growth of Primecare Supply, LLC and GTLL Advisory Group, LLC.
  • The company's Board is currently seeking to improve controls and procedures to remediate deficiencies in internal control over financial reporting.

Key Dates

DateDescription
1999-01-20Company incorporated under the name NEW IFT Corporation.
1999-08-13Amended and Restated Certificate of Incorporation filed to change name to Global Technologies, Ltd.
2021-01-20Convertible Promissory Note dated January 20, 2021, payable to Tri-Bridge Ventures, LLC.
2021-01-27Partial funding of Convertible Note to Tri-Bridge Ventures, LLC.
2021-02-22Convertible Promissory Note dated February 22, 2021, payable to Tri-Bridge Ventures, LLC.
2021-03-02Funding of Convertible Note to Tri-Bridge Ventures, LLC.
2023-05-19Series L Preferred Stock conversion notice submitted by Jetco Holdings, LLC.
2023-11-2210 Fold Services, LLC formed.
2024-02-12GOe3, LLC formed.
2024-03-15Share Exchange Agreement executed for GOe3, LLC acquisition.
2024-06-25Certificate of Designations for Series N Preferred Stock filed.
2024-06-30Company elected to terminate and cancel the GOe3 acquisition and related agreements.
2024-07-01Beginning of fiscal year 2025.
2024-09-03Series P Preferred Stock Certificate of Designations filed.
2024-09-15Primecare Supply, LLC commenced occupancy of leased premises in Tampa, Florida.
2024-10-01Effective date for former officer and director returning Series K Preferred Stock.
2024-11-17Executive Employment Agreement entered into with Fredrick K. Cutcher.
2024-11-22Executive Employment Agreement entered into with H. Wyatt Flippen.
2024-11-22Series N Preferred Stock issued to H. Wyatt Flippen in connection with his employment agreement.
2025-01-01Beginning of fiscal year 2026.
2025-02-02Company issued 125,000 shares of Series N Preferred Stock to H. Wyatt Flippen.
2025-02-28Company issued 30,000 shares of Series P Preferred Stock for cash proceeds of $30,000.
2025-05-01Effective date for adoption of ASU 2020-06.
2025-05-19Primecare Supply, LLC formed.
2025-05-20GTLL Advisory Group, LLC formed.
2025-06-30Company's fiscal year end.
2025-08-20Board of Directors approved designation of Series P Preferred Stock.
2025-08-24Company issued 200,000 shares of Series P Preferred Stock for cash proceeds of $200,000.
2025-09-03Series P Subscription Agreement filed.
2025-09-05Certificate of Designations for Series P Preferred Stock filed.
2025-09-15Primecare Supply, LLC commenced occupancy of leased premises.
2025-11-22Company entered into Executive Employment Agreement with H. Wyatt Flippen.
2025-12-30Annual Report on Form 10-K for the year ended June 30, 2025, filed.
2026-01-01Beginning of the third quarter of fiscal year 2026.
2026-03-31End of the third quarter of fiscal year 2026 and reporting period end date.
2026-06-02Form 10-Q filing date.
2026-06-03Certifications signed by CEO and CFO.

Recommendation

hold

While the company is making strategic shifts towards its core businesses, the significant going concern issues, continued net losses, and ineffective internal controls present substantial risks. A 'hold' recommendation is appropriate for existing investors to monitor the execution of the new strategy and potential capital raises, while new investment is not advised until greater financial stability and improved governance are demonstrated.

Keywords

Global Technologies, 10-Q, Quarterly Report, Healthcare, Wellness, Technology, Procurement, Advisory Services, Primecare Supply, GTLL Advisory, Financial Statements, Net Loss, Going Concern

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.